Quantcast

Latest Acetylcholine Stories

2009-03-24 09:18:54

-A tiny genetic mutation is the key to understanding why nicotine--which binds to brain receptors with such addictive potency--is virtually powerless in muscle cells that are studded with the same type of receptor.

2009-02-10 09:15:24

A research team led by Northwestern University reports that insulin may slow or prevent the damage and memory loss caused by toxic proteins affiliated with Alzheimer’s disease.

d5e5738c0dcb2e74463a0867aebaf17d1
2009-01-23 09:18:29

Duke University Medical System researchers have discovered there are differing taste pathways for nicotine, which could provide a new approach for future smoking-cessation products.

2009-01-12 01:17:00

MADISON, Wis., Jan. 12 /PRNewswire/ -- Mithridion, Inc., a drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease (AD), announced today that it held an initial closing of $2.9 million in Series B Preferred Stock financing.

368802e689ea992f70a4767d2b62435a1
2008-11-18 09:25:18

Scientists have identified a relationship between two proteins in the brain that has links to both nicotine addiction and autism.

2008-10-21 15:00:28

SARASOTA, Fla., Oct. 21 /PRNewswire/ -- A team of world-renowned scientists today announced the launch of Archer Pharmaceuticals, Inc., a new company that will use modern technologies for the identification of novel treatments for Alzheimer's disease.

2008-10-03 12:00:27

REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCall/ -- deCODE genetics today announced the filing of an investigational new drug (IND) application for DG071, the company's novel small-molecule modulator of phosphodiesterase 4 (PDE4), with the US Food and Drug Administration (FDA).

2008-10-01 15:00:50

U.S. biophysicists say they have clarified the mysterious interaction between cholesterol and the brain's neurotransmitter receptors.

2008-09-11 12:00:43

Xel Pharmaceuticals has completed the development of its once-a-week Huperzine A transdermal patch for the treatment of Alzheimer's disease. The prototype transdermal patch can deliver 400800mcg of Huperzine A per day for up to seven days.

2008-09-10 12:00:52

Xel Pharmaceuticals, Inc. announced today the completion of the development of its once-a-week Huperzine A transdermal patch for the treatment of Alzheimer's disease (AD). The prototype transdermal patch can deliver 400-800 mcg of Huperzine A per day for up to seven days.


Word of the Day
tourtiere
  • a meat pie that is usually eaten at Christmas in Quebec
The word 'tourtiere' comes from the French tourte, or passenger pigeon.
Related